Grow-Through and Penetration of the 0.2/0.22 "Sterilizing" Membranes - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Grow-Through and Penetration of the 0.2/0.22 "Sterilizing" Membranes


Pharmaceutical Technology


References

1. US Food and Drug Administration, FDA Guidance Document: Current Good Manufacturing Practice in the Manufacture, Processing, Packing, or Holding of Large Volume Parenterals for Human Use (FDA, Rockville, MD, 1976).

2. K.H. Wallhäusser, "Grow-Through and Blow-Through Effects in Long-Term Sterilization Processes," Die Pharmazeutische Industrie 45 (5), 527–531 (1983).

3. J.A. Simonetti and H.G. Schroeder, "Evaluation of Bacterial Grow-Through," J. Environ. Sci. 27 (6), 27–32 (1984).

4. D.A. Christian and T.H. Meltzer, "The Penetration of Membranes by Organism Grow-Through and Its Related Problems," Ultrapure Water 3 (3), 39–44 (1986).

5. J.R. Carter and R.V. Levy, "Microbial Retention Testing in the Validation of Sterilizing Filtration," in Filtration in the Biopharmaceutical Industry, T.H. Meltzer and M.W. Jornitz, Eds. (Marcel Dekker, New York, NY, 1998).

6. J.W. Carter, "Membrane Techniques (Reverse Osmosis and UltraFiltration)," in Towards Absolute Water, A Survey of Current Water Purification, Proceedings of International Symposium (Lane End, High Wycombe, Bucks, England, May 1976), pp. 103–114.

7. PDA–FDA Special Scientific Forum, "Validation of Microbial Retention of Sterilizing Filters," Bethesda, Maryland, July 12–13, 1995.

8. T.J. Leahy and M.J. Sullivan, "Validation of Bacterial Retention Capabilities of Membrane Filters," Pharm. Technol. 2 (11), 64–75 (1978).

9. S. Sundaram, "Retention of Diminutive Water-Borne Bacteria by Microporous Membrane Filters," presented at the PDA National Meeting, Washington, DC, Dec. 7, 1999.

10. V. Krygier, "Rating of Fine Membrane Filters Used in the Semiconductor Industry," in Transcripts of the Fifth Annual Semiconductor Pure Water Conference (San Francisco, CA, Jan. 1986), pp. 232–251.

11. K. Kawamura, M.W. Jornitz, and T.H. Meltzer, "Absolute or Sterilizing Grade Filtration—What is Required?" PDA J. Paren. Sci. Technol. 54 (6), 485–492 (2000).

12. J. Lindenblatt, M.W. Jornitz, and T.H. Meltzer, "Filter Pore Size versus Process Validation—A Necessary Debate?" Eur. J. Paren. Sci. 7 (3), 67–71 (2002).

13. M.W. Jornitz and T.H. Meltzer, "Sterilizing Filtrations with Microporous Membranes," Pharm. Forum 30 (5), 2–9 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here